Literature DB >> 10545512

Gene transfer for cystic fibrosis.

M J Welsh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10545512      PMCID： PMC409833          DOI： 10.1172/JCI8634

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  18 in total

1.  Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.

Authors:  G Schiedner; N Morral; R J Parks; Y Wu; S C Koopmans; C Langston; F L Graham; A L Beaudet; S Kochanek
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

2.  Monomolecular collapse of plasmid DNA into stable virus-like particles.

Authors:  T Blessing; J S Remy; J P Behr
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

3.  Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus.

Authors:  B G Harvey; P L Leopold; N R Hackett; T M Grasso; P M Williams; A L Tucker; R J Kaner; B Ferris; I Gonda; T D Sweeney; R Ramalingam; I Kovesdi; S Shak; R G Crystal
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

4.  Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions.

Authors:  C Summerford; R J Samulski
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo.

Authors:  A Lieber; C Y He; I Kirillova; M A Kay
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  A chimeric type 2 adenovirus vector with a type 17 fiber enhances gene transfer to human airway epithelia.

Authors:  J Zabner; M Chillon; T Grunst; T O Moninger; B L Davidson; R Gregory; D Armentano
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  CpG motifs in bacterial DNA trigger direct B-cell activation.

Authors:  A M Krieg; A K Yi; S Matson; T J Waldschmidt; G A Bishop; R Teasdale; G A Koretzky; D M Klinman
Journal:  Nature       Date:  1995-04-06       Impact factor: 49.962

8.  Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake.

Authors:  J C Perales; T Ferkol; H Beegen; O D Ratnoff; R W Hanson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

9.  Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis.

Authors:  C S Chu; B C Trapnell; S M Curristin; G R Cutting; R G Crystal
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

10.  Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis.

Authors:  L G Johnson; J C Olsen; B Sarkadi; K L Moore; R Swanstrom; R C Boucher
Journal:  Nat Genet       Date:  1992-09       Impact factor: 38.330
View more
  15 in total

1.  Polarized AAVR expression determines infectivity by AAV gene therapy vectors.

Authors:  Bradley A Hamilton; Xiaopeng Li; Alejandro A Pezzulo; Mahmoud H Abou Alaiwa; Joseph Zabner
Journal:  Gene Ther       Date:  2019-04-08       Impact factor: 5.250

2.  Antibiotic susceptibility and production of endotoxin by Ochrobactrum anthropi isolated from environment and from patients with cystic fibrosis.

Authors:  Dittmar Chmelař; Ondřej Holý; Iveta Kasáková; Michal Hájek; Anna Lazarová; Carlos Gonzalez-Rey; Jakub Lasák; Vladislav Raclavský; Ivan Čižnár
Journal:  Folia Microbiol (Praha)       Date:  2019-03-27       Impact factor: 2.099

3.  AJRCCM: 100-Year Anniversary. Progress along the Pathway of Discovery Leading to Treatment and Cure of Cystic Fibrosis.

Authors:  Bonnie W Ramsey; Michael J Welsh
Journal:  Am J Respir Crit Care Med       Date:  2017-05-01       Impact factor: 21.405

4.  Vesicular stomatitis virus G-pseudotyped lentivirus vectors mediate efficient apical transduction of polarized quiescent primary alveolar epithelial cells.

Authors:  Z Borok; J E Harboe-Schmidt; S L Brody; Y You; B Zhou; X Li; P M Cannon; K J Kim; E D Crandall; N Kasahara
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Targeting the urokinase plasminogen activator receptor enhances gene transfer to human airway epithelia.

Authors:  P T Drapkin; C R O'Riordan; S M Yi; J A Chiorini; J Cardella; J Zabner; M J Welsh
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

6.  Human coronavirus 229E infects polarized airway epithelia from the apical surface.

Authors:  G Wang; C Deering; M Macke; J Shao; R Burns; D M Blau; K V Holmes; B L Davidson; S Perlman; P B McCray
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

Review 7.  Academic, Foundation, and Industry Collaboration in Finding New Therapies.

Authors:  Bonnie W Ramsey; Gerald T Nepom; Sagar Lonial
Journal:  N Engl J Med       Date:  2017-05-04       Impact factor: 91.245

8.  Jaagsiekte sheep retrovirus Env protein stabilizes retrovirus vectors against inactivation by lung surfactant, centrifugation, and freeze-thaw cycling.

Authors:  D A Coil; J H Strickler; S K Rai; A D Miller
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

9.  Bronchoalveolar fluid is not a major hindrance to virus-mediated gene therapy in cystic fibrosis.

Authors:  C P Rooney; G M Denning; B P Davis; D M Flaherty; J A Chiorini; J Zabner
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  GFP-tagged CFTR transgene is functional in the G551D cystic fibrosis mouse colon.

Authors:  D Oceandy; B McMorran; R Schreiber; B J Wainwright; K Kunzelmann
Journal:  J Membr Biol       Date:  2003-04-01       Impact factor: 1.843
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.